Phenylketonuria in Brazil: evolution and cases
Keywords:
metabolism, inborn errors, Phenylketonuria, neonatal screeningAbstract
The objectives of this work were to gather relevant information on phenylketonuria, highlighting the cause, symptoms, dietary treatment, national and international prevalence and to identify the situation of this
metabolic disorder in Brazil. Data were obtained from the National Ministry of Health and phenylketonuria
treatment units in Brazil. In this study, 1225 people who received control and assistance for the disease were
included. One of the main problems detected was that in most of Brazil, phenylketonuria patients have to
leave their home state seeking more qualified treatment centers. In the Northern and Northeastern Regions, little information is available. The results obtained lead to the conclusion that neither newborn screening, nor phenylketonuria treatment centers cover all of the Brazilian cases. Advances in organizing data and actions regarding phenylketonuria have been taking place. Specific foods are restrict and costly. New options are being researched, nevertheless, there is much to be done, mainly on food research and production.
References
Carvalho TM. Resultados do levantamento epidemiológico da sociedade brasileira de triagem neonatal (SBTN). Rev Méd Minas Gerais. 2003; 13(1 Supl 2):S109-35.
Brasil. Lei Federal 8.069 de 13 de julho de 1990. Dispõe sobre o Estatuto da Criança e do Adolescente [Internet]. Brasília; 1990. [acesso 10 mar 2005]. Disponível em: www.presidencia.gov.br/CCivil/Leis/L8069.htm
Associação de Fenilcetonúricos e Homocistinúricos do Paraná. Fenilcetonúria. Curitiba: Fundação Ecumênica de Proteção ao Excepcional; 1999. 10p. Publicação Técnica.
Moats RA, Koch R, Moseley K, Guldberg P, Gutter F, Boles RG. Brain phenylalanine concentration in the management of adults with phenylketonuria. J Inherit Metab Dis. 2000; 23(1):7-14.
Shils ME, Olson JÁ, Shike M. Modern nutrition in health and disease. 8th ed. Philadelphia: Lea & Febiger; 1994. p.1153-68.
Mira NVM, Marquez UML. Importância do diagnóstico e tratamento da Fenilcetonúria. Rev Saúde Pública. 2000; 34(1):86-96.
Elsas JE, Longo N, Rosenberg LE. Distúrbios hereditários do metabolismo e do armazenamento dos aminoácidos. In: Faucy AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, editores. Harrison medicina interna. 14. ed. Rio de Janeiro: McGraw-Hill; 1998. p.2329-34.
Sheard NF. Importance of diet in maternal phenylketonuria. Nutr Rev. 2000; 58(8):236-9.
Sarkissian CN, Gámez, A. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now? Mol Gen Metab. 2005, 86(Suppl 1):22-6.
Diament AJ. Erros inatos do metabolismo: aminoacidopatias. In: Diament AJ, Cypel S, coordenadores. Neurologia infantil. 3.ed. São Paulo: Atheneu; 1998. p.372-85.
Waitzberg DL. Nutrição oral, enteral e parenteral na prática clínica. 3.ed. São Paulo: Atheneu; 2000. p.449-57.
Smith I, Brenton DP. Hiperphenylalaninemias. In: Fernandes J, Saudubray J-M, van Den Berghe G, editores. Inborn metabolic diseases. 2nd ed. New York: Springer-Verlag; 1995. p.147-60.
Tourian A, Sidbury JB. Phenylketonuria and hiperphenylalaninemia. In: Stambury JB, Wyngaarden JB, Fredrickson DS, Doldstein, JL, Brown MS. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill; 1983. p.270-84.
Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hiperphenylalaninemias. In: Scriver RS, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill; 1995. p.1015-75.
Acosta PB, Yannicelli S. Ross Metabolic Formula System: Nutrition Support Protocols, 4th ed. Columbus (OH): Ross Laboratories; 2001.
Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al. Harrison medicina interna.14.ed. Rio de Janeiro: McGraw-Hill; 1998.
Battistini S, Stefano N, Parlanti S, Federico A. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment. Functional Neurol. 1991; 6(2):177-80.
Ishimaru K, Tamasawa, N, Baba, M, Matsunaga M, Takeg K. Phenylketonuria with adult-onset neurological manifestation. Clinical Neurol. 1993; 33(9):961-5.
Thompson AJ, Tillotson S, Smith I, Kendall B, Moore SG, Brenton DP. Neurological deterioration in young adults with phenylketonuria. Lancet. 1990; 336(8715):602-5.
Villasana D, Butler IG, Williams JC, Roongta SM. Neurological deterioration in adult phenylketonuria. J Inher Metab Dis. 1989; 12(4):451-7.
Karam SM. Gestantes com Fenilcetonúria. Rev Méd Minas Gerais. 2003; 13(1 Supl 2):S109-35.
Cerone R, Barella C, Fantasia AR, Schialfino MC. Valutazione di una nuova miscela di aminoacidi per il trattamento della fenilchetonuria. Minerva Pediatr [Internet]. 1999. [cited 2000 Nov 15]. 51(11-12):403-6. Available from: http:/www.bireme.br/ocgi-bin/wxislind.exe/iah/online
Brasil. Ministério da Saúde [Internet]. Brasília; 2001. Portaria n. 822/GM de 6 de junho de 2001. Institui no âmbito do Sistema Único de Saúde, o Programa Nacional de Triagem Neonatal/PNTN. [Acesso 10 mar 2005]. Disponível em: http://dtr2001.saude.gov.br/sas/ PORTARIAS/Port2004/Gm/GM-2695.htm
Ramalho RJR, Ramalho ARO, Oliveira CRP, Oliveira MHA. Evolução do programa de triagem para o Hipotireoidismo Congênito e Fenilcetonúria no Estado de Sergipe de 1995 a 2003. Arq Bras Endocrinol Metab. 2004; 48(6):890-6.
Carvalho TM, Vargas PR, Santos HMP. Dados preliminares. Rev Méd Minas Gerais. 2003; 13(1 Supl 2):S40-106.
Neonatal phenylalanine test kit. Norton (OH): Perking elmer life Sciences Inc; 2001. Technical Bulletin.
Instituto Brasileiro de Geografia e Estatística [Internet]. Rio de Janeiro; 2000. [acesso 17 maio 2002]. Censo demográfico 2000. Disponível em: http://www.ibge.net/home/estatística/populacao/censo2000/tabelagrandesregioes211.shtm
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Lenice Teresinha Bussolotto MONTEIRO, Lys Mary Bileski CÂNDIDO
This work is licensed under a Creative Commons Attribution 4.0 International License.
